Nasal Drug Delivery Systems Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-02-12　·　156 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 98.3 Bn
2033 年預估規模: USD 134.67 Bn
年複合成長率 CAGR: 8.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Nasal Drug Delivery Systems Market, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers and Pressurized Containers), By System Type (Multi Dose, Bi Dose, and Unit Dose), By Therapeutics Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

報告摘要

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The nasal drug delivery systems used in the treatment of pain, acute migraine treatment, allergic and non-allergic rhinitis, and nasal congestion brought on by sinusitis, the common cold, or rhinitis. Nasal medication delivery is typically employed when a beginning of action is desired or when other routes of administration prove unsuccessful. Systemic drug administration and needle-free immunization is possible with the help of nasal drug delivery systems. It is possible to use inhalers, droppers, spray pumps, nebulizers, or atomizers to give liquid nasal solutions. Market Dynamics Increasing research and development activities for nasal drug delivery systems is expected to drive growth of the global nasal drug delivery system market over the forecast period. For instance, on April 5, 2022, Upperton Pharma Solutions, a U.K. based contract development and manufacturing organization (CDMO) had launched a nasal delivery development platform, UpperNose, for small and mid-sized innovators to access the knowledge and capabilities required for the successful development of nasal dose formulations. Furthermore, increasing product approvals by regulatory authorities is expected to drive growth of the nasal drug delivery market over the forecast period. For instance, on October 18, 2021, Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company had announced that the U.S. Food and Drug Administration (FDA) had approved TYRVAYA (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray approved for the treatment of dry eye disease. TYRVAYA Nasal Spray is believed to bind to cholinergic receptors to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment for dry eye disease. Key features of the study • This report provides an in-depth analysis of the global nasal drug delivery systems market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global nasal drug delivery systems market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Merck & Co., Inc., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global nasal drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery systems market Market Segmentation • By Dosage Form o Nasal Spray o Nasal Drops o Nasal Gels o Nasal Powders o Others • By Container Type o Non-pressurized Containers o Pressurized Containers • By System Type o Multi Dose o Bi Dose o Unit Dose • By Therapeutics Application o Allergic and Non-allergic Rhinitis o Nasal Congestion o Vaccination o Others • By Distribution Channel o Hospitals Pharmacies o Retail Pharmacies o Online Pharmacies • By Regional Insights o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Merck & Co., Inc. o GlaxoSmithKline plc o AstraZeneca plc o Johnson & Johnson o Pfizer Inc. o Baxter International, Inc. o Valeant Pharmaceuticals International, Inc. o Becton o Dickinson and Company o Novartis AG

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snippet, By Dosage Form  Market Snippet, By Container Type  Market Snippet, By System Type  Market Snippet, By Therapeutics Application  Market Snippet, By Distribution Channel  Market Snippet, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  PEST Analysis  PORTER’s Five Forces Analysis  Market Opportunities  Regulatory Scenario  Key Developments  Industry Trend 4. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Nasal Spray  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Nasal Drops  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Nasal Gels  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Nasal Powders  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends 5. Global Nasal Drug Delivery Systems Market, By Container Type, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Non-pressurized Containers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Pressurized Containers  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 6. Global Nasal Drug Delivery Systems Market, By System Type, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Multi Dose  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Bi Dose  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Unit Dose  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 7. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Allergic and Non-allergic Rhinitis  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Nasal Congestion  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Vaccination  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Others  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 8. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 - 2033  Segment Trends o Hospital Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Retail Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Online Pharmacies  Market Share Analysis, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends 9. Global Nasal Drug Delivery Systems Market, By Region, 2026-2033, (USD Bn) o Introduction  Market Share Analysis, By Region, 2025, 2028, and 2033 (%)  Y-o-Y Growth Analysis, For Region, 2021 - 2033 o North America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.S. o Canada o Latin America  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Market Share Analysis, By Country, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)  Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033  Market Size and Forecast, By Dosage Form, 2026- 2033, (USD Bn)  Market Size and Forecast, By Container Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By System Type, 2026- 2033, (USD Bn)  Market Size and Forecast, By Therapeutics Application, 2026- 2033, (USD Bn)  Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)  Market Size and Forecast, By Country, 2026- 2033, (USD Bn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Heat Map Analysis o Market Share Analysis (3x3 Matrix) o Company Profiles  Merck & Co., Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  GlaxoSmithKline plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  AstraZeneca plc o Company Overview o Product Type Portfolio o Recent Developments/Updates  Johnson & Johnson o Company Overview o Product Type Portfolio o Recent Developments/Updates  Pfizer Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Baxter International, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Valeant Pharmaceuticals International, Inc. o Company Overview o Product Type Portfolio o Recent Developments/Updates  Becton o Company Overview o Product Type Portfolio o Recent Developments/Updates  Dickinson and Company o Company Overview o Product Type Portfolio o Recent Developments/Updates  Novartis AG o Company Overview o Product Type Portfolio o Recent Developments/Updates 11. Analyst Recommendation o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. Section o References o Research Methodology o About Us and Sales Contact

提及公司

Merck & Co., Inc.GlaxoSmithKline plcAstraZeneca plcJohnson & JohnsonPfizer Inc.Baxter International, Inc.Valeant Pharmaceuticals International, Inc.BectonDickinson and CompanyNovartis AG

同分類最新報告（醫療器材）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們